Skip to content

Inside Nancy Pelosi’s portfolio: 2 stocks she just traded

Inside Nancy Pelosi's portfolio: 2 stocks she just traded
Elmaz Sabovic

Nancy Pelosi, known as one of the most astute U.S. politicians in terms of stock trading, has recently made significant trades that will draw attention from the broader investor community and further solidify her reputation as a savvy trader.

Namely, in a filing made with the Clerk of the House of Representatives on July 30, Pelosi revealed two trades conducted by her husband, Paul Pelosi. These included the purchase of 10,000 Nvidia (NASDAQ: NVDA) shares worth $1.3 million and the sale of 5,000 Microsoft (NASDAQ: MSFT) shares worth $2.2 million.

These market moves by Pelosi occur amid ongoing scrutiny of stock trading activities by Senators, members of Congress, and their families.

Nancy Pelosi's stock trades on July 26. Source: PTR-House
Nancy Pelosi’s stock trades on July 26. Source: PTR-House

In addition to her insider knowledge about the potential legislation that may impact these companies, what makes it more impressive is the trade timing and the subsequent performance of these stocks up until now.

Pelosi timed her stock trades almost perfectly

When looking at the price chart for both MSFT and NVDA stocks since July 26, when Pelosi made her moves in the market, it is evident that her trades were timed almost perfectly.

After she decided to sell 5,000 MSFT shares at $428.60 per share, Microsoft stock fell 2.3% as of the latest close, thus saving herself approximately $100,000.

On the other hand, the California representative purchased 10,000 NVDA shares at an average price of $112.70, which, when pre-market gains on August 1 are included, surged 7.64% since the purchase, earning her around $113,000 so far.

MSFT and NVDA stock performances since Nancy Pelosi’s July 26 trade. Source: Google Finance
MSFT and NVDA stock performances since Nancy Pelosi’s July 26 trade. Source: Google Finance

Pelosi reported several stock trades in July

In addition to the Former House Speaker’s most recent report, Pelosi disclosed her stock trades on one more occasion on July 2, when she filed multiple trades involving Visa (NYSE: V), Broadcom (NASDAQ: AVGO), Tesla (NASDAQ: TSLA), and Nvidia.

With Pelosi’s previous purchase of 10,000 shares of NVDA stock, the Senior Democrat’s combined purchases of the semiconductor giant’s stock in July amounted to $2.5 million.

Her previous trades weren’t as well-timed as the most recent one, as AVGO stock has been 0.18% in the red since then, Nvidia stock is yet to recover losses of 7.99% and TSLA surged 26.01% since she sold 2,000 shares.

Buy stocks now with eToro – trusted and advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.